# Evaluation of elexacaftor–tezacaftor–ivacaftor treatment in individuals with cystic fibrosis and CFTRN1303K in the USA: a prospective, multicentre, open-label, single-arm trial

*PRI Rank #14 · Topics and Trends in Most Cited Pediatric health and respiratory diseases Papers, Class of 2026*

*Canonical URL: https://pri.pepkio.com/top-papers/pediatric-health-and-respiratory-diseases/2026/rank-14*

| Field | Value |
| --- | --- |
| Rank | #14 |
| 18m citations | 21 |
| Journal | The Lancet Respiratory Medicine |
| Year | 2024 |
| DOI | 10.1016/s2213-2600(24)00205-4 |
| Corresponding authors | George M. Solomon |
| Institution | University of Alabama at Birmingham, United States |

**Ranking page:** [Topics and Trends in Most Cited Pediatric health and respiratory diseases Papers, Class of 2026](https://pri.pepkio.com/top-papers/pediatric-health-and-respiratory-diseases/2026)

**Paper link:** [10.1016/s2213-2600(24)00205-4](https://doi.org/10.1016/s2213-2600(24)00205-4)

## Topics

Elexacaftor/tezacaftor/ivacaftor · CFTR N1303K mutation · Cystic fibrosis · CFTR modulator therapy · single-arm trial design · Sweat chloride test · Percent predicted FEV1 · CFTR gating mutation · gene-specific therapy response

## Cite this ranking

```
Pepkio Research Index (PRI). Topics and Trends in Most Cited Pediatric health and respiratory diseases Papers, Class of 2026. https://pri.pepkio.com/top-papers/pediatric-health-and-respiratory-diseases/2026. Accessed 2026-07-14.

Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459
```